首页> 外国专利> DUAL ACTION, INHALED FORMULATIONS PROVIDING BOTH IMMEDIATE AND SUSTAINED RELEASE PROFILE

DUAL ACTION, INHALED FORMULATIONS PROVIDING BOTH IMMEDIATE AND SUSTAINED RELEASE PROFILE

机译:立即采取行动并采取持续措施,采取双重行动,吸入制剂

摘要

PROBLEM TO BE SOLVED: To provide dual action inhaled formulations for immediate and sustained release of a drug, such as anti-infectives delivered by inhalation for the treatment of cystic fibrosis.SOLUTION: There is provided an aerosolized composition of particles, comprising: a free, unencapsulated first pharmaceutically active drug; a pharmaceutically acceptable excipient; and a liposome-encapsulated second pharmaceutically active drug. The aerosolized composition is formulated for aerosolized delivery, wherein the first and the second pharmaceutically active drug are each an anti-infective and the particles of the aerosol have a diameter in a range from about 2 microns to about 4 microns, and the anti-infective is ciprofloxacin.
机译:解决的问题:提供双重作用的吸入制剂,用于药物的即时和持续释放,例如通过吸入递送的抗感染剂治疗囊性纤维化。解决方案:提供了一种雾化的颗粒组合物,包括:游离的,未包封的第一药物活性药物;药学上可接受的赋形剂;和脂质体包封的第二药物活性药物。雾化的组合物被配制用于雾化递送,其中第一和第二药物活性药物各自是抗感染药,并且该气雾剂的颗粒的直径在约2微米至约4微米的范围内,并且该抗感染药是环丙沙星。

著录项

  • 公开/公告号JP2013116909A

    专利类型

  • 公开/公告日2013-06-13

    原文格式PDF

  • 申请/专利权人 ARADIGM CORP;

    申请/专利号JP20130027587

  • 发明设计人 CIPOLLA DAVID C;BLANCHARD JAMES;

    申请日2013-02-15

  • 分类号A61K31/496;A61K9/127;A61K9/12;A61P31;A61K47/12;A61K47/24;A61K47/18;A61K47/36;A61K47/26;A61P11/08;A61P29;A61P11;A61P31/16;A61P11/02;A61P11/06;A61P37/08;A61P31/12;A61K47/32;A61K47/02;A61K47/42;A61K47/44;

  • 国家 JP

  • 入库时间 2022-08-21 17:03:07

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号